Mar 30, 2026 08:32AM

Feb 11, 2026 02:20PM

Jan 30, 2026 12:21PM

Jan 30, 2026 07:45AM

Jan 30, 2026 07:01AM

Jan 30, 2026 12:59AM

Jan 29, 2026 03:07PM Quince Therapeutics (QNCX) Halted, News Pending

Jan 22, 2026 05:00AM

Jan 9, 2026 04:37AM

Jan 6, 2026 05:16AM

Dec 11, 2025 04:15AM

Dec 10, 2025 04:08PM

Nov 13, 2025 06:30AM

Oct 9, 2025 04:07PM Quince Therapeutics presents walking capacity data for rare disease

Oct 3, 2025 04:10AM

Sep 26, 2025 04:23AM

Sep 25, 2025 04:05PM

Aug 12, 2025 04:18AM

Aug 5, 2025 02:35AM

Jul 15, 2025 07:44AM

Jul 10, 2025 04:05PM Quince Therapeutics names Dr. Hassan Abolhassani to advisory board

Jun 12, 2025 05:15PM

May 13, 2025 05:25PM

Mar 25, 2025 07:11AM

Mar 24, 2025 06:03AM

Feb 4, 2025 04:06PM

Dec 18, 2024 04:07PM

Dec 18, 2024 04:05AM Brookline Capital Markets Starts Quince Therapeutics Inc. (QNCX) at Buy

Nov 13, 2024 04:26PM

Nov 12, 2024 04:05PM

Nov 11, 2024 04:05PM

Oct 29, 2024 06:48AM

Oct 22, 2024 07:18AM

Aug 15, 2024 07:01AM

Aug 13, 2024 05:56PM Cortexyme, Inc. (QNCX) Reports Q2 Loss of $0.64

417,337 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All